ey0016.11-12 | Treatment of Severe Obesity: Next Steps | ESPEYB16
EW Iepsen
, J Zhang
, HS Thomsen
, EL Hansen
, M Hollensted
, S Madsbad
, T Hansen
, JJ Holst
, JC Holm
, SS Torekov
To read the full abstract: Cell Metabolism 2018; 28: 2332Pathogenic mutations in the melanocortin-4 receptor gene (MC4R) are the most common cause of monogenic obesity. However, very limited treatment options exist. Therefore, these authors investigated a glucagon-like peptide-1 receptor agonist (GLP-1 RA) as a treatment option for these patients. The findings are of major signific...